Literature DB >> 15753669

Karl Hürthle! Now, who was he?

Patrizio Caturegli1, Christine Ruggere.   

Abstract

The name Hürthle is used in medicine to designate a particular type of thyroid cell, mainly characterized by a granular and deeply eosinophilic cytoplasm. This article describes the life of Karl Hürthle (1860-1945) and the experiments he performed in the early 1890s to explore the morphology and function of the thyroid gland.

Mesh：

Year:  2005        PMID： 15753669     DOI： 10.1089/thy.2005.15.121

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


  5 in total

Review 1.  The significance of hurthle cells in thyroid disease.

Authors:  Jennifer Cannon
Journal:  Oncologist       Date:  2011-09-30

2.  Hürthle cells predict hypothyroidism in interferon-γ transgenic mice of different genetic backgrounds.

Authors:  Shintaro Iwama; Alessandra De Remigis; Justin A Bishop; Hiroaki J Kimura; Patrizio Caturegli
Journal:  Endocrinology       Date:  2012-06-19       Impact factor: 4.736

Review 3.  Oncocytic mania: a review of oncocytic lesions throughout the body.

Authors:  F Guaraldi; G Zang; A P Dackiw; P Caturegli
Journal:  J Endocrinol Invest       Date:  2011-02-07       Impact factor: 4.256

4.  Hürthle Cell Carcinoma of the Thyroid Gland: Systematic Review and Meta-analysis.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Jatin P Shah; Alvaro Sanabria; Abir Al Ghuzlan; Carl E Silver; Ashok R Shaha; Peter Angelos; Dana M Hartl; Antti A Mäkitie; Kerry D Olsen; Randall P Owen; Gregory W Randolph; Ricard Simó; Ralph P Tufano; Luiz P Kowalski; Mark E Zafereo; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2021-08-22       Impact factor: 3.845

5.  Immunoproteasome overexpression underlies the pathogenesis of thyroid oncocytes and primary hypothyroidism: studies in humans and mice.

Authors:  Hiroaki J Kimura; Cindy Y Chen; Shey-Cherng Tzou; Roberto Rocchi; Melissa A Landek-Salgado; Koichi Suzuki; Miho Kimura; Noel R Rose; Patrizio Caturegli
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.